Also, the fact that rs7672915 (intron 2) was significantly associated with our primary outcome when the basis for the analysis was limited to including cohort data with less than 5 years of follow-up may indicate that the PPARGC1A gene plays a role in CHD progression, possibly in repair and recovery after an initial event in the short term. This evidence concerns the gene PPARGC1A and coronary artery disorder.